Shanghai - Delayed Quote CNY

Jointown Pharmaceutical Group Co., Ltd (600998.SS)

8.21 0.00 (0.00%)
At close: April 26 at 3:00 PM GMT+8
Key Events
Loading Chart for 600998.SS
DELL
  • Previous Close 8.21
  • Open 8.18
  • Bid 8.20 x --
  • Ask 8.21 x --
  • Day's Range 8.08 - 8.34
  • 52 Week Range 6.50 - 8.95
  • Volume 20,114,730
  • Avg. Volume 19,106,032
  • Market Cap (intraday) 32.092B
  • Beta (5Y Monthly) 0.13
  • PE Ratio (TTM) 11.40
  • EPS (TTM) 0.72
  • Earnings Date --
  • Forward Dividend & Yield 0.36 (4.35%)
  • Ex-Dividend Date Jun 29, 2023
  • 1y Target Est 10.18

Jointown Pharmaceutical Group Co., Ltd provides pharmaceutical supply chain services in China. It is also involved in general agency brand promotion; digital retail; intelligent logistics and supply chain solutions; and medical health and technology value-added service businesses. In addition, the company manufactures western medicines, such as antibiotics, anti-diabetic drugs, and cardiovascular drugs; and other OEM medicines. The company was founded in 1999 and is based in Wuhan, China.

www.jztey.com

30,141

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 600998.SS

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

600998.SS
17.12%
SSE Composite Index
3.82%

1-Year Return

600998.SS
6.71%
SSE Composite Index
5.40%

3-Year Return

600998.SS
9.68%
SSE Composite Index
11.10%

5-Year Return

600998.SS
29.57%
SSE Composite Index
1.13%

Compare To: 600998.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 600998.SS

Valuation Measures

Annual
As of 4/27/2024
  • Market Cap

    32.09B

  • Enterprise Value

    34.02B

  • Trailing P/E

    11.33

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.17

  • Price/Book (mrq)

    1.36

  • Enterprise Value/Revenue

    0.22

  • Enterprise Value/EBITDA

    8.17

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.43%

  • Return on Assets (ttm)

    2.63%

  • Return on Equity (ttm)

    7.91%

  • Revenue (ttm)

    151.84B

  • Net Income Avi to Common (ttm)

    2.17B

  • Diluted EPS (ttm)

    0.72

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    14.48B

  • Total Debt/Equity (mrq)

    57.82%

  • Levered Free Cash Flow (ttm)

    2.47B

Research Analysis: 600998.SS

Analyst Price Targets

5.50 Low
10.18 Average
8.21 Current
13.24 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: 600998.SS

People Also Watch